Finance

Lists
Why is OXB up 2,69%?
Dive Deeper
OXB:LON
Oxford BioMedica plc
535,00 GBX
+2,69%
(+14,00) 1D
12-окт., 16:37:38 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OXB...
Open
522,00 GBX
High
546,00 GBX
Low
522,00 GBX
Mkt. cap
647,62 млн
Avg. vol.
798,53 миң
Volume
245,54 миң
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 млн
No. of employees
1 миң
Open
522,00 GBX
High
546,00 GBX
Low
522,00 GBX
Mkt. cap
647,62 млн
Avg. vol.
798,53 миң
Volume
245,54 миң
52-wk high
962,00 GBX
52-wk low
420,00 GBX
EPS
-0,34 GBX
Shares outstanding
121,05 млн
No. of employees
1 миң
News stories
From web sources and news partners
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOFrank Mathias
Employees1,02 миң
Founded1995
Headquarters-
Sector-
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
47,76 млн
47,76 млн
39,92 млн
39,92 млн
Cost of goods sold
30,60 млн
30,60 млн
25,35 млн
25,35 млн
Cost of revenue
30,60 млн
30,60 млн
25,35 млн
25,35 млн
Research and development expenses
1,54 млн
1,54 млн
1,14 млн
1,14 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 млн
19,65 млн
24,36 млн
24,36 млн
Operating expense
20,93 млн
20,93 млн
25,29 млн
25,29 млн
Total operating expenses
51,52 млн
51,52 млн
50,64 млн
50,64 млн
Operating income
-3,76 млн
-3,76 млн
-10,72 млн
-10,72 млн
Other non operating income
-323,00 миң
-323,00 миң
-141,50 миң
-141,50 миң
EBT including unusual items
-2,95 млн
-2,95 млн
-18,11 млн
-18,11 млн
EBT excluding unusual items
-7,26 млн
-7,26 млн
-14,29 млн
-14,29 млн
Income tax expense
-1,07 млн
-1,07 млн
372,00 миң
372,00 миң
Effective tax rate
36,20%
36,20%
-2,05%
-2,05%
Other operating expenses
-259,50 миң
-259,50 миң
-212,50 миң
-212,50 миң
Net income
-1,88 млн
-1,88 млн
-18,48 млн
-18,48 млн
Net profit margin
-3,94%
-3,94%
-46,29%
-46,29%
Earnings per share
-
-
-
-
Interest and investment income
649,50 миң
649,50 миң
917,00 миң
917,00 миң
Interest expense
-3,55 млн
-3,55 млн
-3,94 млн
-3,94 млн
Net interest expenses
-2,90 млн
-2,90 млн
-3,02 млн
-3,02 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,06 млн
-2,06 млн
-7,43 млн
-7,43 млн
Gain or loss from assets sale
53,00 миң
53,00 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору